Slcllal enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens

Diabetes

Volumn 58, Issue 1, 2009, Pages 156-164

  Dai, Yang D ^a   Marrero, Idania G ^a   Gros, Philippe ^b   Zaghouani, Habib ^c   Wicker, Linda S ^d   Sercarz, Eli E ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c University of Missouri   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PANCREAS ISLET CELL ANTIBODY; B7 ANTIGEN; CATION TRANSPORT PROTEIN; HLA ANTIGEN CLASS 2; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1;

ACIDIFICATION; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; GENOTYPE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; ANIMAL; AUTOIMMUNITY; CELL CULTURE; CYTOLOGY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PATHOPHYSIOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD80; AUTOIMMUNITY; BLOTTING, WESTERN; CATION TRANSPORT PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; ISLETS OF LANGERHANS; MACROPHAGES; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; PHAGOCYTOSIS; T-LYMPHOCYTES;

EID: 63249113539     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1608     Document Type: Article

References (47)

1. Hill NJ, Lyons PA, Armitage N, Todd JA, Wicker LS, Peterson LB: NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 49:1744-1747, 2000
2. Wicker LS, Chamberlain G, Hunter K, Rainbow D, Howlett S, Tiffen P, Clark J, Gonzalez-Munoz A, Cumiskey AM, Rosa RL, Howson JM, Smink LJ, Kingsnorth A, Lyons PA, Gregory S, Rogers J, Todd JA, Peterson LB: Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J Immunol 173:164-173, 2004
3. Kissler S, Stern P, Takahashi K, Hunter K, Peterson LB, Wicker LS: In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat Genet 38:479-483, 2006
4. Hunter K, Rainbow D, Plagnol V, Todd JA, Peterson LB, Wicker LS: Interactions between Idd5.1/Ctla4 and other type 1 diabetes genes. J Immunol 179:8341-8349, 2007
5. Vidal SM, Malo D, Vogan K, Skamene E, Gros P: Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73:469-485, 1993
6. Cellier M, Govoni G, Vidal S, Kwan T, Groulx N, Liu J, Sanchez F, Skamene E, Schurr E, Gros P: Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J Exp Med 180:1741-1752, 1994
7. Stober CB, Brode S, White JK, Popoff JF, Blackwell JM: Slcllal, formerly Nrampl, is expressed in dendritic cells and influences major histocompat-ibility complex class II expression and antigen-presenting cell function. Infect Immun 75:5059-5067, 2007
8. Blackwell JM: Structure and function of the natural-resistance-associated macrophage protein(Nramp1), a candidate protein for infectious and autoimmune disease susceptibility. Mol Med Today 2:205-211, 1996
9. Gruenheid S, Pinner E, Desjardins M, Gros P: Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J Exp Med 185:717-730, 1997
10. Searle S, Bright NA, Roach TI, Atkinson PG, Barton CH, Meloen RH, Blackwell JM: Localisation of Nramp1 in macrophages: modulation with activation and infection. J Cell Sci 111:2855-2866, 1998
11. White JK, Stewart A, Popoff JF, Wilson S, Blackwell JM: Incomplete glycosylation and defective intracellular targeting of mutant solute carrier family 11 member 1(Slcllal). Biochem J 382:811-819, 2004
12. Vidal SM, Pinner E, Lepage P, Gauthier S, Gros P: Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycopro-tein absent in macrophages from susceptible(Nramp1 D169)mouse strains. J Immunol 157:3559-3568, 1996
13. Malo D, Vogan K, Vidal S, Hu J, Cellier M, Schurr E, Fuks A, Bumstead N, Morgan K, Gros P: Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 23:51-61, 1994
14. Govoni G, Vidal S, Cellier M, Lepage P, Malo D, Gros P: Genomic structure, promoter sequence, and induction of expression of the mouse Nramp1 gene in macrophages. Genomics 27:9-19, 1995
15. Searle S, Blackwell JM: Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet 36:295-299, 1999
16. Blackwell JM, Searle S, Mohamed H, White JK: Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol Lett 85:197-203, 2003
17. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K: Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 11:729-766, 1993
18. Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G, Malo D, Skamene E, Olivier M, Jothy S, Gros P: The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 182:655-666, 1995
19. Gregg RK, Jain R, Schoenleber SJ, Divekar R, Bell JJ, Lee HH, Yu P, Zaghouani H: A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J Immunol 173:7308-7316, 2004
20. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, Moura IC, Lennon-Dumenil AM, Seabra MC, Raposo G, Amigorena S: NOX2 controls phagosomal pH to regulate antigen processing during cross-presentation by dendritic cells. Cell 126:205-218, 2006
21. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993
22. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune esponse to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72-75, 1993
23. Katz JD, Wang B, Haskins K, Benoist C, Mathis D: Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089-1100, 1993
24. Haskins K, Portas M, Bergman B, Lafferty K, Bradley B: Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA86:8000-8004, 1989
25. Bergman B, McManaman JL, Haskins K: Biochemical characterization of a beta cell membrane fraction antigenic for autoreactive T cell clones. J Autoimmun 14:343-351, 2000
26. Barrera LF, Kramnik I, Skamene E, Radzioch D: I-A beta gene expression regulation in macrophages derived from mice susceptible or resistant to infection with M. bovis BCG. Mol Immunol 34:343-355, 1997
27. Jabado N, Jankowski A, Dougaparsad S, Picard V, Grinstein S, Gros P: Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1(Nramp1)functions as a pH-dependent manganese transporter at the phagosomal membrane. J Exp Med 192:1237-1248, 2000
28. Hackam DJ, Rotstein OD, Zhang W, Gruenheid S, Gros P, Grinstein S: Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1(Nrampl)impairs phagosomal acidification. J Exp Med 188:351-364, 1998
29. Goswami T, Bhattacharjee A, Babal P, Searle S, Moore E, Li M, Blackwell JM: Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter. Biochem J 354:511-519, 2001
30. Serreze DV, Gaskins HR, Leiter EH: Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150:2534-2543, 1993
31. Piganelli JD, Martin T, Haskins K: Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes 47:1212-1218, 1998
32. O'Keeffe M, Brodnicki TC, Fancke B, Vremec D, Morahan G, Maraskovsky E, Steptoe R, Harrison LC, Shortman K: Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development. Int Immunol 17:307-314, 2005
33. Yan G, Fu Y, Faustman DL: Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic(NOD)mouse due to a mutation in their shared bidirectional promoter. J Immunol 159:3068-3080, 1997
34. Kessler BM, Lennon-Dumenil AM, Shinohara ML, Lipes MA, Ploegh HL: LMP2 expression and proteasome activity in NOD mice. Nat Med 6:1064, 2000
35. Serreze DV, Bridgett M, Chapman HD, Chen E, Richard SD, Leiter EH: Subcongenic analysis of the Idd13 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for beta 2-microglobulin. J Immunol 160:1472-1478, 1998
36. Davoodi-Semiromi A, Laloraya M, Kumar GP, Purohit S, Jha RK, She JX: A mutant Stat5b with weaker DNA binding affinity defines a key defective pathway in nonobese diabetic mice. J Biol Chem 279:11553-11561, 2004
37. Litherland SA, Grebe KM, Belkin NS, Paek E, Elf J, Atkinson M, Morel L, Clare-Salzler MJ, McDuffie M: Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility,
38. macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproduction. J Immunol 175:4561-4565, 2005
39. Fox CJ, Danska JS: Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation. Diabetes 47:331-338, 1998
40. Maehr R, Mintern JD, Herman AE, Lennon-Dumenil AM, Mathis D, Benoist C, Ploegh HL: Cathepsin L is essential for onset of autoimmune diabetes in NOD mice. J Clin Invest 115:2934-2943, 2005
41. Mellanby RJ, Koonce CH, Monti A, Phillips JM, Cooke A, Bikoff EK: Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes. J Immunol 177:7588-7598, 2006
42. Castellino F, Zappacosta F, Coligan JE, Germain RN: Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J Immunol 161:4048-4057, 1998
43. Sercarz E, Wilbur S, Sadegh-Nasseri S, Miller A, Manca F, Gammon G, Shastri N: The molecular context of a determinant influences its dominant expression in a T cell response hierarchy through "fine processing". Progress in Immunology IV: Sixth International Congress of Immunology 6:227-237, 1986
44. Nelson CA, Vidavsky I, Viner NJ, Gross ML, Unanue ER: Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc Natl Acad SciUSA94:628-633, 1997
45. Rudensky A, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr: Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622-627, 1991
46. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, Strominger JL: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764-768, 1992
47. Dai YD, Jensen KP, Marrero I, Li N, Quinn A, Sercarz EE: N-terminal flanking residues of a diabetes-associated GAD65 determinant are necessary for activation of antigen-specific T cells in diabetes-resistant mice. Eur J Immunol 38:968-976, 2008